How Zubretsky was paid
$18.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Pension | Other | Total |
|---|---|---|---|---|---|
| Joseph M. ZubretskyPresident and Chief Executive Officer | $1,600,000 | $16,199,988 | — | $540,795 | $18,340,783 |
| Mark L. KeimChief Financial Officer | $1,000,000 | $6,250,135 | — | $312,049 | $7,562,184 |
| James E. WoysChief Operating Officer | $800,000 | $4,500,109 | — | $56,409 | $5,356,518 |
| Jeff D. BarlowChief Legal Officer and Secretary | $685,000 | $3,500,053 | $159,234 | $51,037 | $4,395,324 |
| Debra J. BaconExecutive Vice President, Medicaid | $675,000 | $2,200,066 | $8,630 | $48,031 | $2,931,727 |
What changed and why
- $18.3MJoseph M. Zubretsky received total compensation of $18,340,783 in 2025, reflecting a decrease from $21,944,109 in 2024.
- Short-term cash incentive payouts for named executive officers were zero for fiscal year 2025.
- Stock awards comprised the largest portion of executive compensation through PSUs and RSAs.
- The CEO-to-median employee pay ratio was 228 to 1 for the year.
- Stockholders engaged significantly following the 2025 say-on-pay vote regarding retention grants.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.